Product Image
More sustainable than new
$228.85$549.70Save 58%

Product Details

Manufacturer
SKU
HPA005785WB
Shipped From
Sweden

About this product

Anti-CD44

by Atlas Antibodies · SKU HPA005785WB

Overview

The Anti-CD44 antibody (HPA005785) is a rabbit Triple A Polyclonal reagent targeting human CD44, a widely expressed adhesion molecule with roles in cell motility, extracellular matrix interaction, and lymphocyte activation. The antibody is produced using a recombinant region enriched in low-complexity extracellular motifs. Validated only for Western blot, it supports detection of CD44 isoforms in human lysates.

Highlights

  • Rabbit Triple A Polyclonal antibody recognising human CD44
  • Validated exclusively for Western blot (WB)
  • Recombinant extracellular immunogen sequence
  • Formulated in PBS with glycerol and preservative

At-a-glance

Antigen
CD44 (CD44 molecule, Indian blood group)
Antibody type
Triple A Polyclonal
Host species
Rabbit
Isotype
IgG
Validation
Western blot (WB) only
Immunogen sequence
DDVSSGSSSERSSTSGGYIFYTFSTVHPIPDEDSPWITDSTDRIPATTLMSTSATATETATKRQETWDWFSWLFLPSESKNHLHTTTQMAGTSSNTISAGWEPNEENEDERDRHLSFSGSGIDDDEDFISSTISTTPR
Buffer composition
40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Condition
New

Applications

This antibody enables Western blot detection of CD44, supporting analyses of cell adhesion, isoform diversity, and tissue-specific expression profiles in human samples.

Sustainability

By rehoming surplus lab products, this listing supports waste reduction and resource efficiency.

Related Products

What Our Clients Say

Supporting innovation at leading research companies

RNAnalytics

RNAnalytics

Leading The Way In Gene Therapy Analytics

As a startup focused on developing analytical toolkits for LNP characterization, RNAnalytics operates under tight budget constraints while striving to maintain a fully stocked lab with high-quality materials. Sustainability is also a core pillar of our operations, pushing us to make environmentally conscious decisions wherever possible....